Literature DB >> 29970926

Normative and conceptual ELSI research: what it is, and why it's important.

Lisa S Parker1, Pamela L Sankar2, Joy Boyer3, J D Jean McEwen3, David Kaufman3.   

Abstract

The Ethical, Legal, and Social Implications (ELSI) Research Program of the National Human Genome Research Institute sponsors research examining ethical, legal, and social issues arising in the context of genetics/genomics. The ELSI Program endorses an understanding of research not as the sole province of empirical study, but instead as systematic study or inquiry, of which there are many types and methods. ELSI research employs both empirical and nonempirical methods. Because the latter remain relatively unfamiliar to biomedical and translational scientists, this paper seeks to elucidate the relationship between empirical and nonempirical methods in ELSI research. It pays particular attention to the research questions and methods of normative and conceptual research, which examine questions of value and meaning, respectively. To illustrate the distinct but interrelated roles of empirical and nonempirical methods in ELSI research, including normative and conceptual research, the paper demonstrates how a range of methods may be employed both to examine the evolution of the concept of incidental findings (including the recent step toward terming them 'secondary findings'), and to address the normative question of how genomic researchers and clinicians should manage incidental such findings.

Entities:  

Keywords:  ELSI research; incidental findings; normative issues; research methods; values and meaning

Mesh:

Year:  2018        PMID: 29970926     DOI: 10.1038/s41436-018-0065-x

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  1 in total

1.  Clinical genome sequencing and population preferences for information about 'incidental' findings-From medically actionable genes (MAGs) to patient actionable genes (PAGs).

Authors:  Thomas Ploug; Søren Holm
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

  1 in total
  7 in total

1.  Ethical, legal, and social issues (ELSI) in rare diseases: a landscape analysis from funders.

Authors:  Adam L Hartman; Anneliene Hechtelt Jonker; Melissa A Parisi; Daria Julkowska; Nicole Lockhart; Rosario Isasi
Journal:  Eur J Hum Genet       Date:  2019-09-19       Impact factor: 4.246

Review 2.  Assessing Pain Research: A Narrative Review of Emerging Pain Methods, Their Technosocial Implications, and Opportunities for Multidisciplinary Approaches.

Authors:  Sara E Berger; Alexis T Baria
Journal:  Front Pain Res (Lausanne)       Date:  2022-06-02

3.  Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the "My Personal Breast Screening" (MyPeBS) randomised clinical trial.

Authors:  Alexandra Roux; Rachel Cholerton; Jonathan Sicsic; Nora Moumjid; David P French; Paolo Giorgi Rossi; Corinne Balleyguier; Michal Guindy; Fiona J Gilbert; Jean-Benoit Burrion; Xavier Castells; David Ritchie; Debbie Keatley; Camille Baron; Suzette Delaloge; Sandrine de Montgolfier
Journal:  BMC Cancer       Date:  2022-05-06       Impact factor: 4.638

4.  Three decades of ethical, legal, and social implications research: Looking back to chart a path forward.

Authors:  Deanne Dunbar Dolan; Sandra Soo-Jin Lee; Mildred K Cho
Journal:  Cell Genom       Date:  2022-06-27

5.  Anticipating the ethical, legal, and social implications of human genome research: An ongoing experiment.

Authors:  Eric T Juengst
Journal:  Am J Med Genet A       Date:  2021-06-22       Impact factor: 2.802

6.  Family-level impact of genetic testing: integrating health economics and ethical, legal, and social implications.

Authors:  Hadley Stevens Smith; Amy L McGuire; Eve Wittenberg; Tara A Lavelle
Journal:  Per Med       Date:  2021-03-17       Impact factor: 2.512

7.  A systematic approach to the disclosure of genomic findings in clinical practice and research: a proposed framework with colored matrix and decision-making pathways.

Authors:  Kenji Matsui; Keiichiro Yamamoto; Shimon Tashiro; Tomohide Ibuki
Journal:  BMC Med Ethics       Date:  2021-12-25       Impact factor: 2.652

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.